Owlet reports record Q2 2026 revenue, subscription growth
Health-tech firm Owlet posted its highest quarterly revenue on record in Q2 2026, driven by a surge in subscription services, lifting shares in after-hours trading.
Owlet released preliminary financial results for the second quarter of 2026, reporting record revenue and a significant increase in subscription-based services.
The health technology company, known for its infant monitoring devices, said total revenue for Q2 2026 exceeded prior-period highs, with subscription services contributing the largest share of growth. While the company did not disclose exact figures, it noted that recurring revenue streams had expanded materially compared to the same period last year.
Shares of Owlet surged in after-hours trading following the announcement, reflecting investor optimism about the company’s revenue trajectory and the scalability of its subscription model. The company has emphasized the shift toward recurring revenue as a key pillar of its long-term strategy, particularly in light of competitive pressures in the wearables market.
Owlet has not yet filed its full earnings report with regulatory authorities, and further details regarding profitability, margins, and segment performance are expected in the coming weeks. The preliminary results indicate a continuation of the company’s growth trend, though analysts caution that sustained subscription adoption will be critical to maintaining momentum.
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →